RAYMOND JAMES & ASSOCIATES - GLOBUS MED INC ownership

GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 243 filers reported holding GLOBUS MED INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of GLOBUS MED INC
ValueSharesWeighting
Q3 2023$21,487,560
+3.4%
432,781
+24.0%
0.02%
+5.9%
Q2 2023$20,787,366
+32.6%
349,133
+26.2%
0.02%
+21.4%
Q1 2023$15,671,761
-65.5%
276,691
-54.8%
0.01%
-66.7%
Q4 2022$45,475,892
+77.1%
612,305
+42.0%
0.04%
+61.5%
Q3 2022$25,678,000
+107.0%
431,051
+95.1%
0.03%
+116.7%
Q2 2022$12,402,000
-0.3%
220,909
+31.0%
0.01%
+20.0%
Q1 2022$12,442,000
+4.1%
168,642
+1.9%
0.01%0.0%
Q4 2021$11,954,000
-4.7%
165,574
+1.1%
0.01%
-9.1%
Q3 2021$12,548,000
-3.0%
163,769
-1.8%
0.01%
-8.3%
Q2 2021$12,933,000
+15.8%
166,817
-7.9%
0.01%
+9.1%
Q1 2021$11,168,000
-25.8%
181,098
-21.5%
0.01%
-35.3%
Q4 2020$15,053,000
+14.9%
230,807
-12.8%
0.02%
+6.2%
Q3 2020$13,101,000
+24.8%
264,567
+20.2%
0.02%
+14.3%
Q2 2020$10,498,000
+38.2%
220,029
+23.2%
0.01%
+16.7%
Q1 2020$7,597,000
+64.0%
178,636
+127.0%
0.01%
+100.0%
Q4 2019$4,633,000
+6.9%
78,678
-7.2%
0.01%0.0%
Q3 2019$4,335,000
+118.1%
84,806
+80.5%
0.01%
+100.0%
Q2 2019$1,988,000
+72.3%
46,990
+101.1%
0.00%
+50.0%
Q1 2019$1,154,000
+84.3%
23,361
+61.4%
0.00%
+100.0%
Q4 2018$626,000
-4.9%
14,474
+24.9%
0.00%0.0%
Q3 2018$658,000
+20.1%
11,587
+6.7%
0.00%0.0%
Q2 2018$548,000
+54.4%
10,863
+52.3%
0.00%0.0%
Q1 2018$355,000
-57.5%
7,133
-64.9%
0.00%
-50.0%
Q4 2017$836,000
-55.6%
20,347
-67.9%
0.00%
-50.0%
Q3 2017$1,885,000
-8.0%
63,420
+2.6%
0.00%0.0%
Q2 2017$2,050,000
+23.9%
61,828
+10.6%
0.00%0.0%
Q1 2017$1,655,000
+19.9%
55,888
+0.5%
0.00%0.0%
Q4 2016$1,380,000
+10.8%
55,622
+0.9%
0.00%
+33.3%
Q3 2016$1,245,000
-7.2%
55,147
-2.0%
0.00%
-25.0%
Q2 2016$1,341,000
-0.9%
56,275
-1.2%
0.00%
-20.0%
Q1 2016$1,353,000
-12.6%
56,984
+2.4%
0.01%
-16.7%
Q4 2015$1,548,000
+18.3%
55,642
-12.2%
0.01%
+20.0%
Q3 2015$1,309,000
-18.4%
63,367
+1.3%
0.01%
-16.7%
Q2 2015$1,605,000
-59.3%
62,527
-60.0%
0.01%
-64.7%
Q1 2015$3,943,000
+139.1%
156,232
+125.2%
0.02%
+112.5%
Q4 2014$1,649,00069,3760.01%
Other shareholders
GLOBUS MED INC shareholders Q2 2017
NameSharesValueWeighting ↓
Sterling Investment Advisors, Ltd. 197,873$11,109,0003.82%
Pembroke Management, LTD 600,148$33,692,0003.48%
Godshalk Welsh Capital Management, Inc. 73,101$4,104,0002.95%
PARADIGM CAPITAL MANAGEMENT INC/NY 688,000$38,624,0002.62%
XXEC, Inc. 50,625$2,842,0002.26%
Van Berkom & Associates Inc. 885,922$49,736,0002.08%
GENEVA CAPITAL MANAGEMENT LLC 1,351,998$75,901,0001.75%
RTW INVESTMENTS, LP 1,121,527$62,963,0001.63%
Global Alpha Capital Management Ltd. 257,131$14,435,0001.56%
Ophir Asset Management Pty Ltd 258,889$6,622,381,0001.36%
View complete list of GLOBUS MED INC shareholders